1. Home
  2. CADL vs SCD Comparison

CADL vs SCD Comparison

Compare CADL & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$5.16

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo LMP Capital and Income Fund Inc.

SCD

LMP Capital and Income Fund Inc.

HOLD

Current Price

$15.35

Market Cap

356.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
SCD
Founded
1999
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
356.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
SCD
Price
$5.16
$15.35
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.0M
46.2K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
9.63%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$13.79
52 Week High
$7.24
$16.89

Technical Indicators

Market Signals
Indicator
CADL
SCD
Relative Strength Index (RSI) 55.57 57.37
Support Level $5.15 $15.37
Resistance Level $5.25 $15.72
Average True Range (ATR) 0.22 0.35
MACD 0.05 0.08
Stochastic Oscillator 97.39 78.57

Price Performance

Historical Comparison
CADL
SCD

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About SCD LMP Capital and Income Fund Inc.

Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.

Share on Social Networks: